Do you want to read an article? Please log in or register.
On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF
Heart Failure
Related content
RECOMMENDED
Heart Failure
Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Am Heart J
Sanna GD, Erre GL, Cameli M, Guerra F, Pastore MC, Marini A, Campora A, Gironella P, Costamagna M, Mandoli GE, Casiraghi M, Scuteri A, Lisi M, Casu G, Deidda M, Dessalvi CC, REAL-HF investigators
doi: 10.1016/j.ahj.2024.08.018
Heart Failure
In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial
J Am Heart Assoc
Nouhravesh N, Cyr D, Hernandez AF, Morrow DA, Velazquez EJ, Ward J, Sarwat S, Sharma K, Williamson K, Starling RC, Lepage S, Zieroth S, Solomon SD, Mentz RJ
doi: 10.1161/JAHA.124.037899
Heart Failure
Association of a remote monitoring programme with all-cause mortality and hospitalizations in patients with heart failure: National-scale, real-world evidence from a 3-year propensity score analysis of the TELESAT-HF study
Eur J Heart Fail
Girerd N, Barbet V, Seronde MF, Benchimol H, Jagu A, Tartière JM, Hanon O, Picard F, Lafitte S, Lemaitre M, Pages N, Nisse-Durgeat S, Jourdain P
doi: 10.1002/ejhf.3563
Heart Failure
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry
Eur J Heart Fail
Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C
doi: 10.1002/ejhf.3565
Atrial FibrillationHeart Failure
Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis
Heart Rhythm
Bulhões E, Antunes VLJ, Mazetto R, Defante MLR, Garcia AC, Guida C
doi: 10.1016/j.hrthm.2024.04.058
Heart Failure
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE
Eur J Heart Fail
Ferreira JP, Blatchford JP, Teerlink JR, Kosiborod MN, Angermann CE, Biegus J, Collins SP, Tromp J, Nassif ME, Psotka MA, Comin-Colet J, Mentz RJ, Brueckmann M, Nordaby M, Ponikowski P, Voors AA
doi: 10.1002/ejhf.3369
Heart Failure
Multiregional Implementation Initiative's Impact on Guideline-Based Performance Measures for Patients Hospitalized With Heart Failure: IMPLEMENT-HF
Circ Heart Fail
Sauer AJ, Beon C, Cherkur S, Mallas-Serdynski L, Thomas K, Spertus J, Chahoud G, Mody KP, Saltzberg MT, Goldberg LR, Lindenfeld J, Sweitzer N, Butler J, Kittleson MM, Pina I, Paul S, Lewis EF, Wald J, Allen LA, Jessup M, Congdon M, Kiser R, Yancy C, Fonarow GC
doi: 10.1161/CIRCHEARTFAILURE.124.012547
Heart Failure
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial
Eur J Heart Fail
Tromp J, Kosiborod MN, Angermann CE, Collins SP, Teerlink JR, Ponikowski P, Biegus J, Ferreira JP, Nassif ME, Psotka MA, Brueckmann M, Blatchford JP, Steubl D, Voors AA
doi: 10.1002/ejhf.3218
Heart Failure
Temporal Trends in Mortality and Hospitalization Risk in Patients With Heart Failure According to the Hospital Frailty Risk Score
J Am Heart Assoc
Abassi NK, Nouhravesh N, Elmegaard M, Austreim M, Zahir D, Garred CH, Butt JH, Andersen CF, Strange JE, Sindet-Pedersen C, Christensen DM, Fosbøl E, Andersson C, Køber L, Schou M
doi: 10.1161/JAHA.124.037973